首页> 外文会议>Symposium of Risk Analysis and Risk Management in Western China >Financial Situation of Listed Companies in Pharmaceutical Industry
【24h】

Financial Situation of Listed Companies in Pharmaceutical Industry

机译:制药业上市公司的财务状况

获取原文
获取外文期刊封面目录资料

摘要

This paper studies the financial risks of listed companies in China's pharmaceutical industry by means of qualitative research and quantitative research. Based on the financial data of Guizhou bailing pharmaceutical co, ltd. in 2015 and 2016. The empirical analysis shows that: Based on the fuzzy comprehensive evaluation method, the financial situation analysis of the listed companies in the pharmaceutical industry is feasible in the first year and the year of T. The financial status of listed companies in the pharmaceutical industry can be used to predict the financial risks of the pharmaceutical industry listed company T 1 and 2 years.
机译:本文通过定性研究和定量研究研究了中国制药行业上市公司的金融风险。 基于贵州保释药业有限公司的财务数据 2015年和2016年。实证分析表明:基于模糊综合评价方法,制药行业上市公司的财务状况分析在第一年和T的年份可行。上市公司的财务状况 制药行业可用于预测制药业上市公司T和2年的制药业的金融风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号